Product Information
LORAZEPAM 2 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0696 per EA under NDC 64980062950. Its NADAC has been published 18 times since Feb 25, 2026.
Strength
2 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980062950
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA218597On Market Since
7/24/2025
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 2 MG TABLET has been published 18 times since Feb 25, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0696 per EA |
|---|---|
| All-time high | $0.0706 (Apr 15, 2026) |
| All-time low | $0.0695 (Feb 25, 2026) |
| 52-week high | $0.0706 |
| 52-week low | $0.0695 |
| Median price | $0.0706 |
| Average price | $0.0703 |
| Largest weekly change | +1.6% (Mar 18, 2026) |
| Weeks tracked | 18 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LORAZEPAM 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 2 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0696 per EA (NDC 64980062950), effective Jun 24, 2026.
How has the price of LORAZEPAM 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 2 MG TABLET has held within roughly two percent of its current level. It has been tracked across 18 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 2 MG TABLET?
Since Feb 25, 2026, the NADAC for LORAZEPAM 2 MG TABLET has ranged from a low of $0.0695 (Feb 25, 2026) to a high of $0.0706 (Apr 15, 2026), with a median of $0.0706 per EA.
Are there cheaper alternatives to LORAZEPAM 2 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LORAZEPAM 2 MG TABLET, is $0.0424 per EA — about 39% below LORAZEPAM 2 MG TABLET.
Who manufactures LORAZEPAM 2 MG TABLET?
LORAZEPAM 2 MG TABLET (NDC 64980062950) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification